Abstract Acetylcholine (ACh) elicits vasodilation by releasing a number of endothelium-derived relaxing factors (EDRFs). We used the isolated perfused hydronephrotic rat kidney to examine the characteristics of ACh-induced vasodilation of renal afferent arterioles during different types of underlying vasoconstriction. Basal arteriolar tone was increased by either elevating perfusion pressure to 180 mm Hg (myogenic), administering 0.3 gsmol/L norepinephrine (NE), or elevating medium potassium concentration to 30 mmol/L (KCl). ACh (10 gmol/L) completely reversed myogenic and NE-induced vasoconstriction and reversed KCl-induced vasoconstriction by 80±5%. However, whereas ACh produced a sustained vasodilation during KCI-and NE-induced vasoconstriction, only a transient reversal of myogenic vasoconstriction was observed, and myogenic tone recovered within 5 to 10 minutes. ACh-induced vasodilation of arterioles preconstricted with KCI was markedly inhibited by either indomethacin (100 ,umol/L) or nitro-L-arginine (100 gmol/L) and was completely abolished by pretreatment with both inhibitors. In contrast, indomethacin and nitro-L-arginine had no effect on the transient response to ACh observed during pressureinduced vasoconstriction. In vessels preconstricted with NE, nitro-L-arginine converted the normally sustained response to ACh to a transient vasodilation, which was refractory to both nitric oxide synthase and cyclooxygenase inhibition. Since this component was not observed during KCl-induced vasoconstriction, it may reflect the actions of an, as yet unidentified, endothelium-derived hyperpolarizing factor (EDHF). Our findings thus suggest that prostanoids, nitric oxide, and EDHF all contribute to ACh-induced renal afferent arteriolar vasodilation and that the relative contributions of these individual EDRFs depends on the nature of the underlying renal vascular tone. (Circ Res. 1994;75:821-828 
cetylcholine (ACh) induces vasodilation by stim- ulating the release of endothelium-derived relaxing factors (EDRFs) in a variety of vascular beds.'-3 Although nitric oxide (NO) appears to account for the actions of ACh in many settings,4 elimination of NO (eg, by hemoglobin or NO-synthase inhibitors) does not always prevent endothelium-dependent vasodilation. [5] [6] [7] Thus, evidence has accrued suggesting that EDRFs other than NO may contribute to vascular actions of ACh.8 1l It is well appreciated that ACh stimulates the endothelial production of vasodilatory prostaglandins.12-14 Furthermore, recent evidence suggests that an endothelium-derived hyperpolarizing factor (EDHF) may also contribute to the vasodilatory actions of ACh.9,10 Thus, EDRFs distinct from NO may mediate a part of the ACh-induced vasodilation. ACh is a potent vasodilator of the renal afferent arteriole15- '9; however, the mechanisms mediating the renal microvascular responses to ACh are not clearly defined. NO promotes vasodilation by stimulating soluble guanylate cyclase and increasing intracellular levels of cGMP. 2021 We have previously demonstrated that in isolated perfused hydronephrotic rat kidneys, myogenic or pressure-induced vasoconstriction of the afferent arteriole is insensitive to the vasorelaxant action of cGMP-related substances, including atrial natriuretic peptide (ANP), nitroprusside, and 8-bromo-cGMP. 22 These findings suggested a reasonable approach in the investigation of the possible role of non-NO EDRFs in the renal microvascular response to ACh. Since NO acts via cGMP and cGMP has little effect on myogenic vasoconstriction in our model, we reasoned that investigations with this model may reveal a contributory role of EDRFs other than NO in the renal microvasculature. Thus, during pressure-induced afferent arteriolar vasoconstriction, EDHF and prostaglandins may play a greater role than NO in ACh-induced vasodilation. On the other hand, when the same vessel is constricted by elevating external potassium,23 the anticipated effects of a hyperpolarizing factor would be minimal.9-1' Therefore, we investigated the effects of ACh on myogenic and norepinephrine-and KCI-induced vasoconstriction of the afferent arteriole in the isolated perfused hydronephrotic rat kidney. We examined the effects of nitro-L-arginine (N-Arg) and indomethacin on ACh-induced vasodilation to determine the relative contributions of NO and prostanoids to ACh-induced vasoconstriction in each setting.
Materials and Methods

Animal Preparation
Chronic hydronephrosis was established to facilitate direct visualization of the renal microcirculation.24 Six-week-old male Sprague-Dawley rats (Charles River Breeding Laboratories, Wilmington, Mass) were anesthetized with methoxyflurane (Pitman-Moore). The right ureter was ligated through a small abdominal incision. After 8 to 10 weeks, tubular atrophy of the right kidney had progressed to a stage that allowed direct microscopic visualization of the renal microvessels. The hydronephrotic kidneys were excised and perfused in vitro as described below and detailed in previous communications.22 '23 27 Perfusion of Hydronephrotic Kidneys
The animals were anesthetized with methoxyflurane. The renal artery of the hydronephrotic kidney was cannulated in situ by introducing the arterial cannula through the superior mesenteric artery and across the aorta. An infusion of warm oxygenated medium was administered during the cannulation procedure and was continued during isolation and excision of the kidney. The hydronephrotic kidney was perfused on an inverted microscope (Nikon, model K) modified to accommodate a heated chamber equipped with a thin-glass viewing port on the bottom surface. Kidneys were allowed to equilibrate for at least 30 minutes before initiating the experimental protocol.
The apparatus used to study the hydronephrotic kidney in vitro is illustrated in previous publications.22 '23'25-27 The perfusate consisted of a Krebs-Ringer bicarbonate buffer containing (mmol/L) sodium 145, potassium 5, MgSO4 2.4, CaCI2 2.0, and D-glucose 5, along with 7.5% bovine serum albumin (Bovuminar, Armour Pharmaceutical Co) and a complement of amino acids as detailed previously. 28 The perfusate was saturated with 95% 02/5% C02. Perfusion pressure was monitored within the renal artery and was altered by adjusting a back-pressure-type regulator (model 1OBP, Fairchild Industrial Products Co), controlling the exit of gas from the pressurized reservoir.
Vessel diameters were measured as detailed previously.222325-27 Video images were recorded, transmitted to an IBM-AT computer equipped with a video acquisition and display board (model IVG-128, Datacube), and analyzed by custom-designed image processing. Vessel segments "=50 ,um in length were analyzed at 2-to 5-second intervals. Diameters were estimated from the mean distance between parallel edges of the selected vascular segment. Mean vessel diameters were obtained by averaging all determinations obtained during the plateau of the response.
Experimental Protocols
The vasodilatory effects of ACh (Sigrna Chemical Co) were assessed under three experimental conditions: during KClinduced, norepinephrine (NE)-induced, and pressure-induced vasoconstriction. In the first series of experiments, after the determination of basal afferent arteriolar diameters, the potassium concentration of the perfusate was elevated from 5 to 30 mmol/L by the isosmotic addition of medium in which KCl was substituted for NaCl. ACh was then added directly into the perfusate to achieve the concentrations desired.
In a second series of experiments, the effects of ACh on the NE-induced vasoconstriction were assessed. In these studies, renal arterial pressure (RAP) was maintained constant at 80 mm Hg during the entire experimental procedure when these agents were administered. We have previously demonstrated that an increase in RAP elicits marked afferent arteriolar vasoconstriction (ie, myogenic vasoconstriction) in the isolated perfused hydronephrotic kidney.2227 In the third series of experiments, we examined the effects of ACh on the pressure-induced vasoconstriction of this vessel. Initially, RAP was maintained constant at 80 mm Hg. Thereafter, RAP was elevated to 180 mm Hg to elicit myogenic vasoconstriction. ACh at final concentrations ranging from 10 nmol/L to 10,umol/L was then administered into the medium, and the afferent arteriolar responses were observed continuously at least for 20 minutes.
N-Arg (Sigma) and indomethacin (Sigma) were used to assess the contributions of NO and prostaglandins to AChinduced vasodilation. Either N-Arg (100 ,umol/L) or indomethacin (100 ,umol/L) was added to the perfusate before induction of the afferent arteriolar vasoconstriction by KCl, NE, or pressure. The afferent arteriolar response to ACh was then assessed in the same settings as described above. In those studies in which N-Arg was administered, L-arginine was omitted from the perfusate.
Analysis of Data
All data are expressed as mean+SEM. Data were analyzed by one-way ANOVA followed by Student's t test. Changes within experimental groups were subjected to paired analysis; differences between groups were assessed by unpaired analysis. Values of P<.05 were considered statistically significant. (23.8 ,um) . Mean data obtained using this protocol are summarized in In the present study, ACh dilated afferent arterioles that were preconstricted with either KCl, NE, or elevated renal perfusion pressure. However, the characteristics of ACh-induced vasodilation differed substantially in each of these experimental settings. First, whereas ACh caused sustained vasodilation of arterioles constricted with KCl and NE, it produced only a transient vasodilation of arterioles preconstricted by elevated pressure. Second, at the highest concentration (10 ,mol/L), ACh only partially reversed KCl-induced vasoconstriction (ie, 80+±5% reversal) but completely reversed the vasoconstrictor responses to NE and pressure. Finally, blockade of NO and prostaglandin synthesis produced markedly different effects in each setting. During KCI-induced vasoconstriction, ACh-induced vasodilation was substantially inhibited by either N-Arg or indomethacin and was completely prevented by the combined treatment with these two agents. In contrast, the transient vasodilation observed during myogenic vasoconstriction was totally unaffected by N-Arg and/or indomethacin treatment. The pharmacological characteristics of ACh-induced vasodilation of vessels preconstricted with NE fell somewhat between these two extremes. N-Arg treatment fully inhibited the sustained component of ACh-induced vasodilation during NE-induced vasoconstriction. However, this treatment unmasked an initial transient dilation that was insensitive to N-Arg or indomethacin and thus similar in nature to the ACh-induced response observed in vessels preconstricted with elevated pressure. These observations indicate differing mechanisms of ACh-induced vasodilation in each of these three settings.
Previous in vivo studies have demonstrated an obligatory role of NO in the vasodilatory response of the renal microcirculation to ACh. Tolins et a132 and Lahera et a133 reported that ACh-induced renal vasodilation is largely prevented by NG-monomethyl-L-arginine. These effects were reversed by excess L-arginine, demonstrating a dependence on NO synthase. On the other hand, evidence also suggests that factors other than NO contribute to ACh-induced renal vasodilation. For Majid and Navar13 demonstrated that in the presence of N-Arg, indomethacin attenuates ACh-induced increases in renal blood flow in vivo, indicating that vasodilatory prostanoids mediate a component of ACh-induced renal vasodilation. ACh stimulates endothelial production of both NO and vasodilatory prostaglandins.4 '12 In the present study, indomethacin and N-Arg blocked ACh-induced vasodilation to similar degrees during KCl-induced vasoconstriction. In this setting, it appears that both NO and prostanoid production are required for the full vasodilatory response to ACh, suggesting synergistic actions of these two EDRFs. NO and prostanoids promote vasodilation by augmenting intracellular cGMP and cAMP, respectively. Studies in isolated aortic smooth muscle indicate that vasoconstriction elicited by KCl-induced reflect the actions of the purported hyperpolarizing factor (EDHF).
The results of our studies examining the nature of ACh-induced vasodilation during NE-induced vasoconstriction also suggest contributions from multiple EDRFs. In this setting, ACh normally produced a sustained vasodilation. The sustained component of this response, however, was completely blocked by N-Arg. As discussed above, NE-induced vasoconstriction is quite sensitive to cGMP-dependent vasodilators such as NO (eg, Fig 9) . Similarly, Ito and colleagues17,18 demonstrated that the afferent arteriolar responses to angiotensin II17 and endothelin'8 are very sensitive to alterations in basal NO production. Such observations would explain the marked effects of NO synthase inhibition on renal hemodynamics and vasodilatory responses to ACh in experimental settings in which renin levels and renal sympathetic tone are enhanced. However, in our studies a transient ACh-induced dilation remained after NO synthase blockade and/or cyclooxygenase inhibition, suggesting the actions of a third EDRF. Similarly, Nagao and Vanhoutte"l have reported that the normally sustained ACh-induced vasodilation in rat femoral vein is converted to a transient response by N-Arg.
The transient vasodilatory component of the AChinduced response in arterioles preconstricted by pressure or NE is mediated by a factor distinct from NO or prostaglandins. The temporal character of this response is similar to that ascribed to an EDHF.3031 The AChinduced vasodilations decayed with a time constant of -2 minutes, completely subsiding within :10 minutes.
In rat aorta, main pulmonary artery, 30 Hoffend et a146 examined regional effects of NG-nitro-L-arginine methyl ester (L-NAME) on pressure-dependent arteriolar tone in the in vivo hydronephrotic kidney preparation. These authors found that L-NAME had no effect on pressure-dependent tone and autoregulation in cortical nephrons but that L-NAME treatment potentiated autoregulatory responses and increased the pressure-dependent tone of juxtamedullary nephrons. The responses of juxtamedullary vessels were not examined in the present study. Of note, it has recently been suggested that NO derived from the macula densa mediates tubuloglomerular feedback-dependent arteriolar responses.47 Tubular atrophy would eliminate any contribution of this mechanism in our preparation.
In summary, the present study demonstrates conclusively two important aspects of the renal microvascular actions of ACh. First, it is apparent from our findings that endothelial factors other than NO contribute to the renal microvascular actions of ACh. Second, the determinants of ACh-induced renal vasodilation appear to vary depending on the nature of the underlying renal vascular tone. As demonstrated previously, endothelium-derived NO may be the major factor responsible for ACh-induced vasodilation during neural-or hormonalinduced renal vasoconstriction. In contrast, other EDRFs (eg, EDHF and prostaglandins) may be more important mediators of ACh-induced vasodilation under conditions in which pressure-induced or myogenic tone is the primary determinant of basal renal vascular resistance.
